Ionis Pharmaceuticals, Inc. (IONS) Debt / Equity
- 2025-12-31: Debt/Equity Ratio 3.6.
- 2024-12-31: Debt/Equity Ratio 2.04.
- 2023-12-31: Debt/Equity Ratio 3.21.
- 2022-12-31: Debt/Equity Ratio 2.05.
Complete source-backed debt/equity ratio history.
- Available history
- 2022-12-31 to 2025-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 3.6 |
| 2024-12-31 | 2.04 |
| 2023-12-31 | 3.21 |
| 2022-12-31 | 2.05 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 3.6 |
| 2024-12-31 | 2.04 |
| 2023-12-31 | 3.21 |
| 2022-12-31 | 2.05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |